Betamethasone Dipropionate Gel Manufacturing

This subcontract involves the manufacture and supply of Betamethasone Dipropionate Gel for prime contractors under Department of Defense supply contracts. The selected provider must formulate an augmented gel base using Carbomer 940 NF, Propylene Glycol USP, Purified Water USP, and Sodium Hydroxide NF, ensuring each gram contains 0.643 mg of Betamethasone Dipropionate USP. The total delivery requirement consists of 50,000 15-gram tubes. To qualify, the manufacturer must maintain valid FDA registration and prescription drug manufacturing licensure while adhering strictly to USP/NF standards. The contract is managed by the Medical Supply Chain Pharm FSA and specifies Fort Bragg as the place of performance. Interested parties must respond by September 30, 2026.